written on 01.04.2014
Tags:
,

FDA lambastes GSK plant for releasing contaminated products

TAGS: ,

Much has been made as of late of the manufacturing problems found at some of India's biggest drugmakers. But a warning letter sent in March to a GlaxoSmithKline active pharmaceutical ingredient plant in Cork, Ireland, illustrates that Big Pharma is not immune to quality issues.

Latest Report